Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Business News Renter's insurance Labor economy
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Breaking News: Business Business News Pharmaceuticals
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Health & Science Pharmaceuticals Obesity
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Exchange/traded funds Health & Science ETF Edge
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Companies Breaking news CVS Health Corp
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Investment Strategy LVMH Moet Hennessy Louis Vuitton SE Business
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Social issues Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Pharmaceuticals Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Pharmaceuticals Markets Europe Markets
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags U/S/ Markets Eli Lilly and Co Health & Science
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags Markets Investing stocks
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Goldman Sachs Group Inc Goldman Sachs BDC Inc Markets
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Markets Investing Alphabet Inc
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags World Markets Daily Open Paramount Global
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Reliance Steel & Aluminum Co Alphabet Inc Markets
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Eli Lilly and Co Medifast Inc Health & Science
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Novo Nordisk A/S Dogs Health insurance
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Zealand Pharma A/S UnitedHealth Group Inc Healthy Returns
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags LVMH Moet Hennessy Louis Vuitton SE Household Products Roche Holding AG
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Pharmaceuticals Markets Zealand Pharma A/S
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Employee benefits Weight management Labor economy
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Biotechnology Novo Nordisk A/S Health care industry
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Mergers Business News Pharmaceuticals
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Europe Markets Earnings Investing
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Starbucks Corp Business News 5 Things to Know
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Sanofi SA Johnson & Johnson US: News
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Roche Holding AG Companies Structure Therapeutics Inc
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.